Page last updated: 2024-09-03

piperaquine and Kidney Diseases

piperaquine has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Liu, Z; Xie, Y; Xing, J; Zhang, L; Zhang, Y	1

Other Studies

1 other study(ies) available for piperaquine and Kidney Diseases

Article	Year
Metabolism is not a Major Contributor to the Toxicity of Piperaquine, a Long-acting Antimalarial Agent in Artemisinin-based Combination Therapy. Current drug metabolism, 2021, Volume: 22, Issue:10 Topics: Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Chemical and Drug Induced Liver Injury; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Inactivation, Metabolic; Kidney Diseases; Metabolic Networks and Pathways; Mice; NF-kappa B; Piperazines; Quinolines; Tumor Suppressor Protein p53	2021

Article

Year

Metabolism is not a Major Contributor to the Toxicity of Piperaquine, a Long-acting Antimalarial Agent in Artemisinin-based Combination Therapy.

Current drug metabolism, 2021, Volume: 22, Issue:10

Topics: Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Chemical and Drug Induced Liver Injury; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Inactivation, Metabolic; Kidney Diseases; Metabolic Networks and Pathways; Mice; NF-kappa B; Piperazines; Quinolines; Tumor Suppressor Protein p53

2021